1AXFORD S E,SHARP N,ROSS P E,et al.Cell biology of laryngeal epithelial defenses in health and disease:preliminary studies[J].Ann Otol Rhinol Laryngol,2001,110:1099-1108. 被引量：1
2GILL G A,JOHNSTON N,BUDA A,et al.Laryngeal epithelial defenses against laryngopharyngeal reflux:investigations of e-cadherin,carbonic anhydrase isoenzyme Ⅲ and pepsin[J].Ann Otol Rhinol Laryngol,2005,114:913-921. 被引量：1
3JOHNSTON N,DETTMAR P W,LIVELY M O,et al.Effect of pepsin on laryngeal stress protein (Sep70,Sep53,and Hsp70) response:role in laryngopharyngeal reflux disease[J].Ann Otol Rhinol Laryngol,2006,115:47-58. 被引量：1
4NOORDZIJ J P,KHIDR A,DESPER E,et al.Correlation of pH probe-measured laryngop haryngeal reflux with symptoms and signs of reflux laryngitis[J].Laryngoscope,2002,112:2192-2195. 被引量：1
5POSTMA G N,BELAFSKY P C,AVIV J E,et al.Laryngopharyngeal reflux testing[J].Ear Nose Throat J,2002,81(Suppl 2):14-18. 被引量：1
6BELAFSKY P C,POSTMA G N,AMIN M R,et al.Symptoms and finding of laryngopharyngeal reflux[J].Ear Nose Throat J,2002,81(Suppl 2):10-14. 被引量：1
7COHEN J T,BACH K K,POSTMA G N,et al.Clinical manifestations of laryngop haryngeal reflux[J].Ear Nose Throat J,2002,81(Suppl 2):19-23. 被引量：1
8BELAFSKY P C,POSTMA G N,KOUFMAN J A.Validity and reliability of the reflux symptom index (RSI)[J].J Voice,2002,16:274-277. 被引量：1
9BELAFSKY P C,POSTMA G N,KOUFMAN J A.The validity and reliability of the reflux finding score (RFS)[J].Laryngoscope,2001,111:1313-1317. 被引量：1
10KNIGHT J,LIVELY M O,JOHNSTON N,et al.Sensitive pepsin immunoassay for detection of laryngopharyngeal reflux[J].Laryngoscope,2005,115:1473-1478. 被引量：1
4Gabriella der. An overview of proton pump inhibitors[J].Gastroenterology Nursing, 2003, 26(5):182. 被引量：1
5Abelo A, Andersson TB, Antonsson M, et al. Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes [J].Drug Metab Dispos, 2000, 28(8):966. 被引量：1
6Kim KA, Kim MJ, Park JY, et al. Stereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes [J]. Drug Metab Dispos, 2003, 31(10):1227. 被引量：1
7Horai TY. Cytochrome P450 and the metabolism of proton pump inhibitors emphasis on rabeprazole[J]. Aliment Pharmacol Ther, 1999, 13 (Suppl 3):27. 被引量：1
8Li XQ, Tommy B, Ahlstrom M, et al. Comparison of inhibitory effects of the proton pump inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities[J]. Drug Metab Dispos, 2004, 32(8):821. 被引量：1
9Radhofer-Welte S. Pharmacokinetics and metabolism of the proton pump inhibitor pantoprazole in man [J]. Drugs Today (Barc), 1999, 35(10):765. 被引量：1
